CY2157B1 - Preparation of pharmaceutical and other matrix systems by solid-state dissolution - Google Patents
Preparation of pharmaceutical and other matrix systems by solid-state dissolutionInfo
- Publication number
- CY2157B1 CY2157B1 CY9900025A CY9900025A CY2157B1 CY 2157 B1 CY2157 B1 CY 2157B1 CY 9900025 A CY9900025 A CY 9900025A CY 9900025 A CY9900025 A CY 9900025A CY 2157 B1 CY2157 B1 CY 2157B1
- Authority
- CY
- Cyprus
- Prior art keywords
- solvent
- matrix
- pharmaceutical
- preparation
- solid
- Prior art date
Links
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B29/00—Layered products comprising a layer of paper or cardboard
- B32B29/06—Layered products comprising a layer of paper or cardboard specially treated, e.g. surfaced, parchmentised
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/38—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents with thermal insulation
- B65D81/3813—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents with thermal insulation rigid container being in the form of a box, tray or like container
- B65D81/3823—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents with thermal insulation rigid container being in the form of a box, tray or like container formed of different materials, e.g. laminated or foam filling between walls
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Mechanical Engineering (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45493889A | 1989-12-22 | 1989-12-22 | |
US07/613,087 US5215756A (en) | 1989-12-22 | 1990-11-06 | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2157B1 true CY2157B1 (en) | 2002-08-23 |
Family
ID=27037662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY9900025A CY2157B1 (en) | 1989-12-22 | 1999-08-17 | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
Country Status (14)
Country | Link |
---|---|
US (3) | US5215756A (xx) |
EP (1) | EP0460185B1 (xx) |
JP (1) | JP3107566B2 (xx) |
KR (1) | KR0173989B1 (xx) |
AT (1) | ATE177006T1 (xx) |
AU (1) | AU646428B2 (xx) |
CA (1) | CA2046310C (xx) |
CY (1) | CY2157B1 (xx) |
DE (1) | DE69032976T2 (xx) |
DK (1) | DK0460185T3 (xx) |
ES (1) | ES2131049T3 (xx) |
GR (1) | GR3029555T3 (xx) |
HK (1) | HK1011279A1 (xx) |
WO (1) | WO1991009591A1 (xx) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR910100193A (el) * | 1991-05-03 | 1993-03-31 | Mediventures Inc | Παρασκευη φαρμακευτικων και αλλων περιβληματων με διαλυση σε στερεα κατασταση. |
US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
DE4140192C2 (de) * | 1991-12-05 | 1996-02-29 | Alfatec Pharma Gmbh | Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen |
DK0617613T3 (da) * | 1991-12-20 | 1996-06-17 | Pfizer | Porøse formgivne afgivelsesindretninger og fremgangsmåde til fremstilling deraf |
US5876754A (en) * | 1992-01-17 | 1999-03-02 | Alfatec-Pharma Gmbh | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
ES2133633T3 (es) * | 1992-01-17 | 1999-09-16 | Alfatec Pharma Gmbh | Procedimiento para la produccion de polvos, granulados o peletes que contienen una sustancia activa, con una estructura a base de macromoleculas hidrofilas, y su utilizacion. |
ATE151631T1 (de) * | 1992-01-17 | 1997-05-15 | Alfatec Pharma Gmbh | Pflanzenwirkstoffextrakt enthaltende kryopelletierte formkörper und ihre pharmazeutische oder kosmetische verwendung |
ES2108258T3 (es) * | 1992-01-17 | 1997-12-16 | Alfatec Pharma Gmbh | Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo. |
DE69331839T2 (de) * | 1992-01-29 | 2002-12-12 | Takeda Chemical Industries Ltd | Schnellösliche Tablette und ihre Herstellung |
HUT75616A (en) * | 1992-03-17 | 1997-05-28 | Pfizer | Method for prooucing porous delivery devices |
US5298261A (en) * | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
IL105553A (en) | 1992-05-06 | 1998-01-04 | Janssen Pharmaceutica Inc | Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water |
WO1994018951A1 (en) * | 1993-02-23 | 1994-09-01 | Warner-Lambert Company | A process for the preparation of substantially alcohol free pharmaceutical compositions |
CA2166891C (en) * | 1993-07-09 | 2001-07-03 | Sang K. Wong | Method for making freeze dried drug dosage forms |
CA2128821A1 (en) * | 1993-07-27 | 1995-01-28 | Dilip J. Gole | Freeze-dried pharmaceutical dosage form and process for separation thereof |
US5457895A (en) * | 1993-10-01 | 1995-10-17 | R. P. Scherer Corporation | Method of identifying freeze-dried dosage forms |
US5382437A (en) * | 1993-10-25 | 1995-01-17 | Hunter Research Corporation | Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5399358A (en) * | 1993-11-12 | 1995-03-21 | Edward Mendell Co., Inc. | Sustained release formulations for 24 hour release of metroprolol |
US6066337A (en) * | 1994-01-27 | 2000-05-23 | The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. | Method for producing a rapidly dissolving dosage form |
US6207199B1 (en) | 1994-01-27 | 2001-03-27 | The Board Of Regents Of The University Of Oklahoma | Process for making a particulate support matrix for making a rapidly dissolving dosage form |
US6187337B1 (en) | 1994-01-27 | 2001-02-13 | The Board Of Regents Of The University Of Oklahoma | Rapidly dissolving dosage form |
US5595761A (en) * | 1994-01-27 | 1997-01-21 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving tablet |
US6177104B1 (en) | 1994-01-27 | 2001-01-23 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving dosage form |
US5635210A (en) * | 1994-02-03 | 1997-06-03 | The Board Of Regents Of The University Of Oklahoma | Method of making a rapidly dissolving tablet |
CA2115592C (en) * | 1994-02-14 | 1998-09-22 | Kumiko Kimura | Production of glucomannan sponge |
US5399359A (en) * | 1994-03-04 | 1995-03-21 | Edward Mendell Co., Inc. | Controlled release oxybutynin formulations |
US5399362A (en) * | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
US5738875A (en) * | 1994-10-28 | 1998-04-14 | R.P. Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
US6726928B2 (en) | 1994-10-28 | 2004-04-27 | R.P. Scherer Technologies, Inc. | Process for preparing solid dosage forms for unpalatable pharmaceuticals |
US5837287A (en) * | 1994-10-28 | 1998-11-17 | R P Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
US5607686A (en) * | 1994-11-22 | 1997-03-04 | United States Surgical Corporation | Polymeric composition |
US5738805A (en) * | 1994-12-23 | 1998-04-14 | Basf Corporation | Process for solubilizing gluten that normally is capable of absorbing water without dissolution |
GB9504201D0 (en) | 1995-03-02 | 1995-04-19 | Scherer Ltd R P | Process for the preparation of a solid pharmaceutical dosage form |
US5958589A (en) * | 1995-07-07 | 1999-09-28 | The United States Of America As Represented By The Secretary Of Agriculture | Starch-based microcellular foams |
US5877224A (en) * | 1995-07-28 | 1999-03-02 | Rutgers, The State University Of New Jersey | Polymeric drug formulations |
AU2068797A (en) * | 1996-01-29 | 1997-08-20 | Edward Mendell Co. Inc. | Sustained release excipient |
US20040023948A1 (en) * | 1997-03-24 | 2004-02-05 | Green Richard David | Fast-dispersing dosage form containing 5-HT1 agonists |
US5976577A (en) * | 1997-07-11 | 1999-11-02 | Rp Scherer Corporation | Process for preparing fast dispersing solid oral dosage form |
FR2766089B1 (fr) * | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
US6296868B1 (en) | 1998-11-19 | 2001-10-02 | Advanced Technology Pharmaceuticals Corporation | Chewable tablets containing mannitol and aspartame |
US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
GB9904049D0 (en) * | 1999-02-22 | 1999-04-14 | Quadrant Holdings Cambridge | Rapidly-soluble compositions |
GB9904629D0 (en) * | 1999-03-02 | 1999-04-21 | Danbiosyst Uk | Oral drug delivery system |
US20060073188A1 (en) * | 1999-03-31 | 2006-04-06 | Pierre Fabre Medicament | Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same |
FR2791569B1 (fr) * | 1999-03-31 | 2003-05-09 | Pf Medicament | Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention |
US6284270B1 (en) | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
IL155959A0 (en) | 2000-11-28 | 2003-12-23 | Fmc Corp | Edible pga (propylene glycol alginate) coating composition |
US6588180B2 (en) | 2001-02-02 | 2003-07-08 | R. P. Scherer Technologies, Inc. | Constricted neck blister pack and apparatus and method for making the same |
FR2822700B1 (fr) * | 2001-04-03 | 2007-04-06 | Frederic Dana | Nouveau produit d'hygiene dentaire sous forme de nutricament unidose gelifiant d'action prolongee et compositions nouvelles adaptees en comprime ou gel semisolide |
WO2003086353A1 (en) * | 2002-04-05 | 2003-10-23 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
US20040018156A1 (en) * | 2002-07-23 | 2004-01-29 | Szeles Lori H | Enzyme enhanced breath freshening film |
AU2003280324A1 (en) | 2002-11-26 | 2004-06-18 | Alk-Abello A/S | Pharmaceutical allergen product |
US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
MXPA05009079A (es) | 2003-02-28 | 2006-05-19 | Alk Abello As | Forma de dosificacion que tiene una matriz de sacarido. |
US7632521B2 (en) * | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
US20050036977A1 (en) * | 2003-08-11 | 2005-02-17 | Dilip Gole | Taste-masked resinate and preparation thereof |
US7972621B2 (en) * | 2004-06-03 | 2011-07-05 | R.P. Scherer Technologies, Llc | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
WO2006020686A1 (en) * | 2004-08-11 | 2006-02-23 | Cadbury Adams Usa Llc | Warming compositions and delivery systems therefor |
ES2277743B2 (es) | 2005-06-02 | 2008-12-16 | Universidade De Santiago De Compostela | Nanoparticulas que comprenden quitosano y ciclodextrina. |
WO2007034287A2 (en) * | 2005-09-19 | 2007-03-29 | University Of The Witwatersrand, Johannesburg | Oramucosal pharmaceutical dosage form |
US9238073B2 (en) * | 2006-04-12 | 2016-01-19 | Wyeth Llc | Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
WO2007138606A2 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
KR101629517B1 (ko) * | 2007-06-01 | 2016-06-13 | 교와 핫꼬 바이오 가부시키가이샤 | 경구 조성물 |
US20090060983A1 (en) * | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
CN101842085B (zh) * | 2007-10-31 | 2013-01-30 | 麦克内尔-Ppc股份有限公司 | 口腔崩解剂型 |
EP2413883A1 (en) | 2009-04-01 | 2012-02-08 | Colgate-Palmolive Company | Dentifrice compositions and methods for treating and preventing damage to tooth surfaces |
US8313768B2 (en) | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
US20110070286A1 (en) * | 2009-09-24 | 2011-03-24 | Andreas Hugerth | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
US9610224B2 (en) * | 2009-09-24 | 2017-04-04 | Johnson & Johnson Consumer Inc. | Manufacture of tablet in a die utilizing powder blend containing water-containing material |
US20110318411A1 (en) | 2010-06-24 | 2011-12-29 | Luber Joseph R | Multi-layered orally disintegrating tablet and the manufacture thereof |
CN107811980B (zh) | 2009-10-30 | 2021-06-18 | Ix 生物医药有限公司 | 快速溶解固体剂型 |
US20120282335A1 (en) | 2010-12-02 | 2012-11-08 | Aptalis Pharmatech Inc. | Rapidly dispersing granules, orally disintegrating tablets and methods |
US8900557B2 (en) | 2010-12-30 | 2014-12-02 | Jr Chem, Llc | Dental cleaning composition |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
MX368159B (es) | 2014-01-10 | 2019-09-20 | Johnson & Johnson Consumer Inc | Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas. |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
JP6868698B2 (ja) | 2016-12-31 | 2021-05-12 | バイオエクセル セラピューティクス,インコーポレイテッド | 激越の治療のための舌下デクスメデトミジンの使用 |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
AU2019226030A1 (en) * | 2018-02-21 | 2020-10-08 | Aron H. BLAESI | Expanding structured dosage form |
MX2020014000A (es) | 2018-06-27 | 2021-06-15 | Bioxcel Therapeutics Inc | Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas. |
BR112022000992A2 (pt) | 2019-07-19 | 2022-06-14 | Arx Llc | Regimes de tratamento de dexmedetomidina não sedantes |
US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB689767A (en) * | 1950-05-22 | 1953-04-01 | Norman James Muschamp | Improvements in or relating to mining machines |
US3285025A (en) * | 1963-12-20 | 1966-11-15 | Phillips Petroleum Co | Multi-stage crystallization process |
NL134880C (xx) * | 1964-08-14 | 1900-01-01 | ||
DE2017373A1 (de) * | 1969-04-15 | 1971-04-22 | Orsymonde S A , Paris | Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung |
CH547473A (de) * | 1972-02-15 | 1974-03-29 | Nestle Sa | Procede de separation d'un solvant et d'une matiere en solution ou en suspension dans le solvant ou impregnee du solvant. |
GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
GB1579818A (en) * | 1977-06-07 | 1980-11-26 | Yamanouchi Pharma Co Ltd | Nifedipine-containing solid preparation composition |
CA1097233A (en) * | 1977-07-20 | 1981-03-10 | George K. E. Gregory | Packages |
US4329281A (en) * | 1978-06-05 | 1982-05-11 | Hoffmann-La Roche Inc. | Hapten compositions |
US4205132A (en) * | 1978-07-17 | 1980-05-27 | Microlife Technics, Inc. | Lyophilization of bacteria |
JPS5679622A (en) * | 1979-12-04 | 1981-06-30 | Kanebo Ltd | Antitumor pharmaceutical |
US4477452A (en) * | 1981-03-26 | 1984-10-16 | American Cyanamid Company | Composition of matter comprising a lyophilized preparation of a penicillin derivative |
IE53696B1 (en) * | 1981-12-02 | 1989-01-18 | Wyeth John & Brother Ltd | Solid shaped articles |
EP0084705B1 (en) * | 1981-12-11 | 1987-01-14 | JOHN WYETH & BROTHER LIMITED | Process for preparing solid shaped articles |
JPS5931715A (ja) * | 1982-08-17 | 1984-02-20 | Toyama Chem Co Ltd | 制癌性物質tf−500の製造法 |
US4818542A (en) * | 1983-11-14 | 1989-04-04 | The University Of Kentucky Research Foundation | Porous microspheres for drug delivery and methods for making same |
US4496684A (en) * | 1984-06-01 | 1985-01-29 | Olin Corporation | Uretdione group-containing polyurethane oligomers and aqueous dispersions thereof |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4851392A (en) * | 1985-02-05 | 1989-07-25 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
US4642903A (en) * | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
US4882154A (en) * | 1985-12-20 | 1989-11-21 | Warner Lambert Co. | Confectionery delivery system for mineral supplements |
US4812445A (en) * | 1987-02-06 | 1989-03-14 | National Starch And Chemical Corporation | Starch based encapsulation process |
US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
US4994273A (en) * | 1987-11-02 | 1991-02-19 | Merck & Co., Inc. | Solubility modulated drug delivery device |
US4840796A (en) * | 1988-04-22 | 1989-06-20 | Dow Corning Corporation | Block copolymer matrix for transdermal drug release |
US5044091B1 (en) * | 1989-04-18 | 1997-12-30 | Sankyo Co | Method of preparing a freeze-dried formulation of a drug |
US4946684A (en) * | 1989-06-20 | 1990-08-07 | American Home Products Corporation | Fast dissolving dosage forms |
US5039540A (en) * | 1989-08-14 | 1991-08-13 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5079018A (en) * | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
-
1990
- 1990-11-06 US US07/613,087 patent/US5215756A/en not_active Expired - Lifetime
- 1990-12-11 JP JP03502774A patent/JP3107566B2/ja not_active Expired - Fee Related
- 1990-12-11 ES ES91902009T patent/ES2131049T3/es not_active Expired - Lifetime
- 1990-12-11 AT AT91902009T patent/ATE177006T1/de not_active IP Right Cessation
- 1990-12-11 DK DK91902009T patent/DK0460185T3/da active
- 1990-12-11 WO PCT/US1990/007319 patent/WO1991009591A1/en active IP Right Grant
- 1990-12-11 DE DE69032976T patent/DE69032976T2/de not_active Expired - Fee Related
- 1990-12-11 EP EP91902009A patent/EP0460185B1/en not_active Expired - Lifetime
- 1990-12-11 AU AU71711/91A patent/AU646428B2/en not_active Ceased
- 1990-12-11 CA CA002046310A patent/CA2046310C/en not_active Expired - Fee Related
-
1991
- 1991-07-23 US US07/734,505 patent/US5330763A/en not_active Expired - Lifetime
- 1991-07-23 US US07/734,636 patent/US5330764A/en not_active Expired - Lifetime
- 1991-08-21 KR KR1019910700954A patent/KR0173989B1/ko not_active IP Right Cessation
-
1998
- 1998-11-24 HK HK98112234A patent/HK1011279A1/xx not_active IP Right Cessation
-
1999
- 1999-03-04 GR GR990400553T patent/GR3029555T3/el unknown
- 1999-08-17 CY CY9900025A patent/CY2157B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0460185A1 (en) | 1991-12-11 |
HK1011279A1 (en) | 1999-07-09 |
ATE177006T1 (de) | 1999-03-15 |
KR920700615A (ko) | 1992-08-10 |
US5330764A (en) | 1994-07-19 |
JP3107566B2 (ja) | 2000-11-13 |
AU646428B2 (en) | 1994-02-24 |
CA2046310C (en) | 2001-10-23 |
US5330763A (en) | 1994-07-19 |
WO1991009591A1 (en) | 1991-07-11 |
DK0460185T3 (da) | 1999-09-27 |
JPH04503959A (ja) | 1992-07-16 |
ES2131049T3 (es) | 1999-07-16 |
EP0460185B1 (en) | 1999-03-03 |
US5215756A (en) | 1993-06-01 |
DE69032976T2 (de) | 1999-08-12 |
KR0173989B1 (en) | 1999-02-01 |
DE69032976D1 (de) | 1999-04-08 |
AU7171191A (en) | 1991-07-24 |
CA2046310A1 (en) | 1991-06-23 |
GR3029555T3 (en) | 1999-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0173989B1 (en) | Preparation of pharmaceutical and other matrix systems by solid-state dissolution | |
DE59104271D1 (de) | Lösungsmittelfreie, oral zu verabreichende pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung und verfahren zu deren herstellung. | |
DE69216642D1 (de) | Verfahren zur herstellung von tabletten mit hoher festigkeit | |
DE3583799D1 (de) | Feste zubereitung mit langsamer freisetzung. | |
GR3026338T3 (en) | High release solid preparation, preparation and use thereof | |
NO870558D0 (no) | Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat. | |
KR970703133A (ko) | 중합체 매트릭스 중의 활성제의 고용체 형태로서의 활성제 제제의 제조 방법 및 그에 의해 얻어진 활성제 제제(Process for Producing Active Agent Preparations in the Form of a Solid Solution of the Active Agent in a Polymer Matrix and Active Agent Preparations Obtained Thereby) | |
DE69212503D1 (de) | Verfahren zur herstellung von porösen abgabevorrichtungen | |
MX10558A (es) | Formulacion de matriz de liberacion sostenida y proceso para preparar un medicamento en tabletas. | |
DK0508653T3 (da) | Farmaceutisk præparat med langvarig frigivelse og fremgangsmåde til at fremstille samme | |
IT1230703B (it) | Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono. | |
ATE143010T1 (de) | Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ES8601756A1 (es) | Metodo de fabricar una estructura compuesta coherente. | |
IL107208A (en) | Process for the preparation of a crop protection agent | |
ATE121936T1 (de) | Isosorbide-5-mononitrate enthaltende tablette mit verzögerter abgabe und verfahren zu ihrer herstellung. | |
EP0246861A3 (en) | Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition | |
EP0435632A3 (en) | Phenylpyrimidine derivatives, process for preparing the same, liquid crystal compositions containing said derivatives as active ingredient, and liquid crystal elements using such compositions | |
Subramanian et al. | The Cu--Er(Copper--Erbium) System | |
BUNTING | Molten salt electrochemical systems[Final Report, 1 Jun. 1980- 31 Mar. 1983] | |
EP0063353A3 (de) | Hochgereinigte informatorische Ribonukleinsäure (i-RNS), Verfahren zur Herstellung und Verwendung derselben | |
TH25006B (th) | ยาเม็ดที่ปล่อยยาอย่างมีการควบคุม | |
TH25006A (th) | ยาเม็ดที่ปล่อยยาอย่างมีการควบคุม | |
NL154507B (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat dat een farmacologisch werkzaam derivaat van een tricyclisch gecondenseerd ringsysteem bevattend aminocarbonzuur bevat alsmede het verkregen gevormde farmaceutische preparaat, en werkwijze voor de bereiding van een voor opnemen in zo'n preparaat geschikt derivaat van een een tricyclisch gecondenseerd ringsysteem bevattend aminocarbonzuur. | |
IT8819182A0 (it) | Derivati dell'ambroxol,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |